• Exchange: Continuous
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ZEL:SM

2.7450 EUR 0.0250 0.90%

As of 11:38:00 ET on 09/15/2014.

Snapshot for Zeltia SA (ZEL)

Open: 2.7750 Day's Range: 2.7200 - 2.7750 Volume: 343,581
Previous Close: 2.7700 52wk Range: 2.2450 - 3.1300 1-Yr Rtn: +10.69%

Stock Chart for ZEL

No chart data available.
  • ZEL:SM 2.7450
  • 1D
  • 1M
  • 1Y
2.7700
Interactive ZEL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZEL

Current P/E Ratio (ttm) 43.0392
Estimated P/E(12/2014) 31.1932
Relative P/E vs. IBEX 2.0079
Earnings Per Share (EUR) (ttm) 0.0638
Est. EPS (EUR) (12/2014) 0.0880
Est. PEG Ratio -
Market Cap (M EUR) 609.95
Shares Outstanding (M) 222.20
30 Day Average Volume 221,075
Price/Book (mrq) 8.8484
Price/Sale (ttm) 4.0930
Dividend Indicated Gross Yield -%
Cash Dividend (EUR) -
Dividend Ex-Date 07/15/2011
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZEL

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ZEL

Zeltia, S.A. is a holding composed of biotechnological and chemical companies. The Company's main activity is developing marine derived anti-cancer drugs and CNS pathologies treatments. Zeltia's other activities include developing diagnosis kits and RNAi technology based therapeutical applications.

Jose Maria Fernandez Sousa-FaroChairmanPedro Francisco Fernandez PuentesVice Chairman
Maria Luisa De Francia CaballeroChief Financial OfficerJose Luis MorenoDir:Capital Market
More Company Profile & Key Executives for ZEL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil